| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |